Author:
Huang Shiew-Mei,Abernethy Darrell R.,Wang Yaning,Zhao Ping,Zineh Issam
Reference58 articles.
1. US FDA innovative drug approvals. Accessed, at: http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm276385.htm.
2. Regulatory science and the role of the regulator in biomedical innovation;Honig;Clin Pharmacol Ther,2012
3. US FDA Safety and Innovation Act (FDASIA). Accessed, at: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/ucm20027187.htm.
4. Medical product development and regulatory science for the 21st century: The critical path vision and its impact on health care;Buckman;Clin Pharmacol Ther,2007
5. The FDA critical path initiative and its influence on new drug development;Woodcock;Annu Rev Med,2008
Cited by
176 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献